Cardioprotection with ischemic preconditioning and MLA: Role of adenosine-regulating enzymes?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Przyklenk, Karin ^a   Zhao, Lin ^b   Kloner, Robert A ^b   Elliott, Gary T ^b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b NONE

Author keywords

5' nucleotidase; adenosine kinase; myocardial infarction; myocardial ischemia

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; DOG; ENZYME ACTIVITY; ENZYME REGULATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTHESIS; LIPID ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SIGNAL TRANSDUCTION;

EID: 33750688590     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.3.h1004     Document Type: Article

References (34)

1. Abd-Elfattah, A. S., and A. S. Wechsler. Superiority of HPLC to assay for enzymes regulating adenine nucleotide pool intermediates: 5′-nucleotidase, adenylate deaminase, adenosine deaminase and adenylosuccinatelyase. A simple and rapid determination of adenosine. J. Liquid Chromatog. 10: 2653-2694, 1987.
2. Arch, J. R. S., and E. A. Newsholme. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem. J. 174: 965-977, 1978.
3. Astiz, M. E., E. C. Rackow, and J. G. Still. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit. Care Med. 23: 9-17, 1995.
4. Bak, M. I., and J. S. Ingwall. Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart: in vivo regulation of 5′-nucleotidase. J. Clin. Invest. 93: 40-49, 1994.
5. Bolling, S. F., D. A. Olszanski, E. L. Bove, and K. F. Childs. Enhanced myocardial protection during global ischemia with 5′-nucleotidase inhibitors. J. Thorac. Cardiovasc. Surg. 103: 73-77, 1992.
6. Darvish, A., and P. J. Metting. Purification and regulation of an AMP-specific cytosolic 5′-nucleotidase from dog heart. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1528-H1534, 1993.
7. Darvish, A., J. J. Postlewaite, and P. J. Metting. Immunogold localization of adenosine 5-monophosphate-specific cytosolic 5′-nucleotidase in dog heart. Hypertension Dallas 21: 906-910, 1993.
8. Downey, J. M., G. S. Liu, and J. D. Thornton. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc. Res. 27: 3-8, 1993.
9. Elliott, G. T., L. Zhao, R. A. McLeod, K. W. Floyd, and G. M. Graves. Cardiac functional preservation by monophosphoryl lipid A in a rabbit model of prolonged regional cardiac ischemia and reperfusion. Int. J. Immunother. 11: 39-48, 1995.
10. Grosso, M. A., A. Banerjee, J. A. St. Cyr, K. B. Rogers, J. M. Brown, D. R. Clark, D. N. Campbell, and A. H. Harken. Cardiac 5′-nucleotidase activity increases with age and inversely relates to recovery from ischemia. J. Thorac. Cardiovasc. Surg. 103: 206-209, 1992.
11. Henricson, B., W. R. Benjamin, and S. N. Vogel. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58: 2429-2437, 1990.
12. Hull-Ryde, E. A., W. R. Lewis, C. D. Veronee, and J. E. Lowe. Simple step gradient elution of the major high-energy compounds and their catabolites in cardiac muscle using high-performance liquid chromatography. J. Chromatogr. 377: 165-174, 1986.
13. 1 receptor activation in the rat cardiomyocytes. J. Clin. Invest. 94: 2451-2456, 1994.
14. Kitakaze, M., M. Hori, T. Morioka, Y. Minamino, S. Takashima, H. Sato, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue, and T. Kamada. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246, 1994.
15. Kitakaze, M., M. Hori, S. Takashima, H. Sato, M. Inoue, and T. Kamada. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation 87: 208-215, 1993.
16. Knowlton, A. A., P. Brecher, and C. S. Apstein. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J. Clin. Invest. 87: 139-147, 1991.
17. Lloyd, H. G. E., and J. Schrader. Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5′-nucleotidase and adenosine kinase. Eur. Heart J. 14, Suppl. I: 27-33, 1993.
18. Marber, M. S., D. S. Latchman, J. M. Walker, and D. M. Yellon. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272, 1993.
19. Murry, C. E., R. B. Jennings, and K.A. Reimer. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
20. Murry, C. E., V. J. Richard, K. A. Reimer, and R. B. Jennings. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66: 913-931, 1990.
21. Nelson, D. W., J. M. Brown, A. Banerjee, D. D. Bensard, K. B. Rogers, C. R. Locke-Winter, B. O. Anderson, and A. H. Harken. Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury. Surgery 110: 365-369, 1991.
22. Pridjian, A. K., E. L. Bove, S. F. Bolling, K. F. Childs, K. M. Brosamer, and F. M. Lupinetti. Developmental differences in myocardial protection in response to 5′ nucleotidase inhibition. J. Thorac. Cardiovasc. Surg. 107: 520-526, 1994.
23. Przyklenk, K., B. Bauer, M. Ovize, R. A. Kloner, and P. Whittaker. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993.
24. Przyklenk, K., M. A. Sussman, B. Z. Simkhovich, and R. A. Kloner. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557, 1995.
25. Savic, S., V. Stefanovic, N. Ardaillou, and R. Ardaillou. Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin 1-β and tumor necrosis factor-α. Immunology 70: 321-326, 1990.
26. Schwann, T. A., K. W. Lobdell, J. Braxton, S. Condos, J. C. Baldwin, and G. S. Kopf. 5′-Nueleotidase inhibition enhances postischemic myocardial performance. J. Surg. Res. 56: 356-360, 1994.
27. Sparks, H. V., and H. Bardenheuer. Regulation of adenosine formation by the heart. Circ. Res. 58: 193-201, 1986.
28. Tavenier, M., A. C. Skladanowski, R. A. DeAbreu, and J. W. de Jong. Kinetics of adenylate metabolism in human and rat myocardium. Biochim. Biophys. Acta 1224: 351-356, 1995.
29. Yao, Z., J. A. Auchampach, G. M. Pieper, and G. J. Gross. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc. Res. 27: 832-838, 1993.
30. ATP channels. Circulation 89: 1229-1236, 1994.
31. Yao, Z., J. L. Rasmussen, J. L. Hirt, D. A. Mei, G. M. Pieper, and G. J. Gross. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J. Cardiovasc. Pharmacol. 22: 653-663, 1993.
32. Yoshida, K., M. M. Maaieh, J. B. Shipley, M. Doloresco, N. L. Bernardo, Y. Z. Qian, G. T. Elliott, and R. C. Kukreja. Monophosphoryl lipid A induces pharmacologic "preconditioning" in rabbit hearts without concomitant expression of 70-kilodalton heat shock protein. Mol. Cell. Biochem. 156: 1-8, 1996.
33. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.
34. Zhao, L., C. C. Kirsch, S. R. Hagen, and G. T. Elliott. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). J. Mol. Cell. Cardiol. 28: 197-208, 1996.